Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Notalgia Paresthetica (KOMFORT)

PHASE2CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

January 11, 2021

Primary Completion Date

May 18, 2022

Study Completion Date

June 30, 2022

Conditions
PruritusNotalgia Paresthetica
Interventions
DRUG

difelikefalin 2.0 mg

Oral difelikefalin 2.0 mg administered twice daily

DRUG

Placebo

Oral Placebo administered twice daily

Trial Locations (36)

10029

Cara Therapeutics Study Site, New York

23502

Cara Therapeutics Study Site, Norfolk

27262

Cara Therapeutics Study Site, High Point

29407

Cara Therapeutics Study Site, Charleston

30328

Cara Therapeutics Study Site, Sandy Springs

33063

Cara Therapeutics Study Site, Margate

33134

Cara Therapeutics Study Site, Coral Gables

33144

Cara Therapeutics Study Site, Miami

33162

Cara Therapeutics Study Site, North Miami Beach

43215

Cara Therapeutics Study Site, Columbus

46168

Cara Therapeutics Study Site, Plainfield

46250

Cara Therapeutics Study Site, Indianapolis

70006

Cara Therapeutics Study Site, Metairie

71913

Cara Therapeutics Study Site, Hot Springs

72758

Cara Therapeutics Study Site, Rogers

72916

Cara Therapeutics Study Site, Fort Smith

77401

Cara Therapeutics Study Site, Bellaire

78213

Cara Therapeutics Study Site, San Antonio

78660

Cara Therapeutics Study Site, Pflugerville

84117

Cara Therapeutics Study Site, Salt Lake City

90033

Cara Therapeutics Study Site, Los Angeles

90404

Cara Therapeutics Study Site, Santa Monica

92122

Cara Therapeutics Study Site, San Diego

92708

Cara Therapeutics Study Site, Fountain Valley

99202

Cara Therapeutics Study Site, Spokane

06416

Cara Therapeutics Study Site, Cromwell

Unknown

Cara Therapeutics Study Site, Surrey

Cara Therapeutics Study Site, Winnipeg

Cara Therapeutics Study Site, Markham

Cara Therapeutics Study Site, Peterborough

Cara Therapeutics Study Site, Montreal

Cara Therapeutics Study Site, Markham

Cara Therapeutics Study Site, Montreal

Cara Therapeutics Study Site, Peterborough

Cara Therapeutics Study Site, Surrey

Cara Therapeutics Study Site, Winnipeg

Sponsors
All Listed Sponsors
lead

Cara Therapeutics, Inc.

INDUSTRY